Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 162, Issue 4, pp 430–432 | Cite as

Antibodies to Glutamate Reversed the Amnesic Effects of Proinflammatory S100A9 Protein Fibrils in Aged C57Bl/6 Mice

  • M. A. Gruden
  • T. V. Davydova
  • V. G. Fomina
  • L. A. Vetrile
  • L. A. Morozova-Roche
  • R. D. E. Sewell
Article

Chronic intranasal administration of fibrillar structures of proinflammatory S100A9 protein impaired passive avoidance learning in old C57Bl/6 mice. Combined treatment with S100A9 fibrils and antibodies to glutamate was followed by an increase in horizontal locomotor activity of animals in the open-field test and did not disturb spatial memory.

Key Words

amnesia S100A9 fibrils antibodies to glutamate spatial memory locomotor activity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Acute neuronal injury. The Role of Excitotoxic Programmed Cell Death Mechanisms. Fujikawa DG, ed. New York, 2010.Google Scholar
  2. 2.
    Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA. Abnormalities of the endosomal-lysosomal system in Alzheimer’s disease: relationship to disease pathogenesis. Adv. Exp. Med. Biol. 1996;389:271-280.CrossRefPubMedGoogle Scholar
  3. 3.
    De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer’s disease. Subcell Biochem. 2012;65:329-352.CrossRefPubMedGoogle Scholar
  4. 4.
    Gorbatov VY, Trekova NA, Fomina VG, Davydova TV. Antiamnestic effects of antibodies to glutamate in experimental Alzheimer’s disease. Bull. Exp. Biol. Med. 2010;150(1):23-25.CrossRefPubMedGoogle Scholar
  5. 5.
    Gruden MA, Davudova TB, Malisauskas M, Zamotin VV, Sewell RD, Voskresenskaya NI, Kostanyan IA, Sherstnev VV, Morozova-Roche LA. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 2004;18(2):165-171.Google Scholar
  6. 6.
    Horvath I, Jia X, Johansson P, Wang C, Moskalenko R, Steinau A, Forsgren L, Wågberg T, Svensson J, Zetterberg H, Morozova-Roche LA. Pro-inflammatory S100A9 protein as a robust biomarker differentiating early stages of cognitive impairment in Alzheimer’s disease. ACS Chem. Neurosci. 2016;7(1):34-39.CrossRefPubMedGoogle Scholar
  7. 7.
    Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 1998;18(2)687-697.Google Scholar
  8. 8.
    Kolobov VV, Davydova TV, Fomina VG. Protective action of glutamate antibodies on increased expression of genes of programmed death of rat brain cells induced by injection of a b-amyloid fragment (25-35). Izv. Akad. Nauk. Ser. Biol. 014;(2):133-141Google Scholar
  9. 9.
    Kolobov VV, Fomina VG, Davydova TV. Antibodies to glutamate reduce the neurotoxic effects of Ab(25-35) in prefrontal cortex cell transcriptome. Dokl. Biochem. Biophys. 2012;447:277-279.CrossRefPubMedGoogle Scholar
  10. 10.
    Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front. Neurosci. 2015;9:469.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Malisauskas M, Zamotin V, Jass J, Noppe W, Dobson CM, Morozova-Roche LA. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. J. Mol. Biol. 2003;330(4):879-890.CrossRefPubMedGoogle Scholar
  12. 12.
    Minter MR, Taylor JM, Crack PJ. The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease. J. Neurochem. 2016;136(3): 457-744.CrossRefPubMedGoogle Scholar
  13. 13.
    Vogl T, Gharibyan AL, Morozova-Roche LA. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int. J. Mol. Sci. 2012;13(3)2893-2917.Google Scholar
  14. 14.
    Wang C, Klechikov AG, Gharibyan AL, Wärmländer SK, Jarvet J, Zhao L, Jia X, Narayana VK, Shankar SK, Olofsson A, Brännström T, Mu Y, Gräslund A, Morozova-Roche LA. The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127(4)507-522.Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • M. A. Gruden
    • 1
  • T. V. Davydova
    • 2
  • V. G. Fomina
    • 2
  • L. A. Vetrile
    • 2
  • L. A. Morozova-Roche
    • 3
  • R. D. E. Sewell
    • 4
  1. 1.P. K. Anokhin Research Institute of Normal PhysiologyMoscowRussia
  2. 2.Research Institute of General Pathology and PathophysiologyMoscowRussia
  3. 3.Department of Medical Biochemistry and BiophysicsUmea UniversityUmeaSweden
  4. 4.Cardiff School of Pharmacy and Pharmaceutical SciencesCardiff UniversityCardiffUK

Personalised recommendations